Literature DB >> 17606683

Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients.

Tim R Cressey1, Sawitree Nangola, Yardpiroon Tawon, Mookda Pattarawarapan, Marc Lallemant, Chatchai Tayapiwatana.   

Abstract

We report a novel one-step immunochromatographic strip test for the rapid, qualitative detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients. The sensitivity was 100% (95% confidence interval [95% CI], 97.8 to 100%), and the specificity was 99.5% (95% CI, 97.2 to 99.9%). The limit of detection was 25 ng/ml. Immunochromatographic strip tests are simple, rapid, and cheap assays that could greatly facilitate drug level monitoring in resource-limited settings.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17606683      PMCID： PMC2043209          DOI： 10.1128/AAC.00445-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.

Authors:  J A H Droste; C P W G M Verweij-Van Wissen; D M Burger
Journal:  Ther Drug Monit       Date:  2003-06       Impact factor: 3.681

2.  Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.

Authors:  Kristel M Crommentuyn; Alwin D Huitema; Kees Brinkman; Marchina E van der Ende; Frank de Wolf; Jos H Beijnen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

3.  Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support.

Authors:  Saye H Khoo; Judith Lloyd; Mark Dalton; Alec Bonington; Elizabeth Hart; Sara Gibbons; Peter Flegg; John Sweeney; Edmund G L Wilkins; David J Back
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

4.  Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood.

Authors:  Benjamin H Chi; Alison Lee; Edward P Acosta; Larry E Westerman; Moses Sinkala; Jeffrey S A Stringer
Journal:  HIV Clin Trials       Date:  2006 Sep-Oct

5.  Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.

Authors:  Reshma S Autar; Ferdinand W N M Wit; Jongkol Sankote; Apicha Mahanontharit; Thanomsak Anekthananon; Piroon Mootsikapun; Khanjtta Sujaikaew; David A Cooper; Joep M A Lange; Praphan Phanuphak; Kiat Ruxrungtham; David M Burger
Journal:  Antivir Ther       Date:  2005

6.  Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.

Authors:  A I Veldkamp; R P van Heeswijk; J W Mulder; P L Meenhorst; G Schreij; S van der Geest; J M Lange; J H Beijnen; R M Hoetelmans
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-01       Impact factor: 3.731

7.  Development of a one-step immunochromatographic strip test for the rapid detection of nevirapine (NVP), a commonly used antiretroviral drug for the treatment of HIV/AIDS.

Authors:  M Pattarawarapan; S Nangola; T R Cressey; C Tayapiwatana
Journal:  Talanta       Date:  2006-06-30       Impact factor: 6.057

8.  Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

Authors:  Marc Lallemant; Gonzague Jourdain; Sophie Le Coeur; Jean Yves Mary; Nicole Ngo-Giang-Huong; Suporn Koetsawang; Siripon Kanshana; Kenneth McIntosh; Vallop Thaineua
Journal:  N Engl J Med       Date:  2004-07-09       Impact factor: 91.245

9.  Detection of nevirapine in plasma using thin-layer chromatography.

Authors:  Jeffrey G Dubuisson; Jennifer R King; Jeffrey S A Stringer; Michele L Turner; Chantelle Bennetto; Edward P Acosta
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

10.  Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance.

Authors:  Patricia W H Hugen; David M Burger; Rob E Aarnoutse; Patricia A Baede; Pythia T Nieuwkerk; Peter P Koopmans; Yechiel A Hekster
Journal:  Ther Drug Monit       Date:  2002-10       Impact factor: 3.681
  10 in total
  1 in total

Review 1.  Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Authors:  Kajal Buckoreelall; Tim R Cressey; Jennifer R King
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 5.577
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.